Fjarde Ap Fonden Danaher Corp Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Danaher Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 115,372 shares of DHR stock, worth $26.6 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

115,372

Previous 120,972 4.63%

Holding current value

$26.6 Million

Previous $30.2 Million 6.18%

% of portfolio

0.33%

Previous 0.33%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$239.25 - $280.76 $1.34 Million - $1.57 Million	-5,600 Reduced 4.63%	115,372 $32.1 Million
Q1 2024 Apr 25, 2024	BUY	$224.58 - $256.19 $808,488 - $922,284	3,600 Added 3.07%	120,972 $30.2 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $203,610 - $256,443	1,100 Added 0.95%	117,372 $27.2 Million
Q3 2023 Oct 23, 2023	BUY	$233.08 - $265.59 $186,464 - $212,471	800 Added 0.69%	116,272 $28.8 Million
Q2 2023 Aug 02, 2023	SELL	$224.99 - $256.14 $2.37 Million - $2.7 Million	-10,523 Reduced 8.35%	115,472 $27.7 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $1.28 Million - $1.48 Million	-5,350 Reduced 4.07%	125,995 $31.8 Million
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $1.97 Million - $2.31 Million	-8,177 Reduced 5.86%	131,345 $34.9 Million
Q2 2022 Aug 11, 2022	SELL	$237.11 - $299.66 $3.58 Million - $4.52 Million	-15,100 Reduced 9.77%	139,522 $35.4 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $3.22 Million - $3.95 Million	-12,500 Reduced 7.48%	154,622 $45.4 Million
Q4 2021 Feb 15, 2022	SELL	$292.08 - $329.01 $2.47 Million - $2.78 Million	-8,453 Reduced 4.81%	167,122 $55 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $1.25 Million - $1.52 Million	-4,585 Reduced 2.54%	175,575 $53.5 Million
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $1.82 Million - $2.2 Million	-8,100 Reduced 4.3%	180,160 $48.3 Million
Q1 2021 May 17, 2021	BUY	$212.38 - $245.9 $148,666 - $172,130	700 Added 0.37%	188,260 $42.4 Million
Q4 2020 Feb 12, 2021	SELL	$212.5 - $245.46 $2.32 Million - $2.68 Million	-10,900 Reduced 5.49%	187,560 $41.7 Million
Q3 2020 Nov 13, 2020	BUY	$177.16 - $215.33 $1.56 Million - $1.89 Million	8,800 Added 4.64%	198,460 $42.7 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $1.84 Million - $2.53 Million	14,300 Added 8.15%	189,660 $33.5 Million
Q1 2020 May 11, 2020	SELL	$121.39 - $169.05 $449,143 - $625,485	-3,700 Reduced 2.07%	175,360 $24.3 Million
Q4 2019 Feb 10, 2020	SELL	$133.47 - $153.48 $2.26 Million - $2.6 Million	-16,950 Reduced 8.65%	179,060 $27.5 Million
Q3 2019 Oct 31, 2019	BUY	$135.4 - $146.47 $81,240 - $87,882	600 Added 0.31%	196,010 $28.3 Million
Q2 2019 Jul 17, 2019	SELL	$124.88 - $143.73 $1.55 Million - $1.78 Million	-12,400 Reduced 5.97%	195,410 $27.9 Million
Q1 2019 Apr 29, 2019	BUY	$97.62 - $132.29 $4.57 Million - $6.2 Million	46,834 Added 29.09%	207,810 $27.4 Million
Q4 2018 Jan 31, 2019	SELL	$94.85 - $109.54 $1.19 Million - $1.37 Million	-12,500 Reduced 7.21%	160,976 $16.6 Million
Q3 2018 Nov 09, 2018	SELL	$98.13 - $108.9 $637,158 - $707,087	-6,493 Reduced 3.61%	173,476 $18.9 Million
Q2 2018 Jul 12, 2018	BUY	$96.1 - $103.24 $384 - $412	4 Added 0.0%	179,969 $17.8 Million
Q1 2018 May 07, 2018	BUY	$92.16 - $103.8 $156,026 - $175,733	1,693 Added 0.95%	179,965 $17.6 Million
Q4 2017 Feb 12, 2018	BUY	$85.26 - $94.62 $2.1 Million - $2.33 Million	24,635 Added 16.03%	178,272 $16.5 Million
Q3 2017 Nov 07, 2017	BUY	$79.29 - $88.45 $443,786 - $495,054	5,597 Added 3.78%	153,637 $13.2 Million
Q2 2017 Aug 08, 2017	BUY	N/A	148,040	148,040 $12.5 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account